Prenetics Global Ltd. (PRE)
21.84
-0.16
(-0.73%)
USD |
NASDAQ |
Oct 09, 16:00
21.76
-0.08
(-0.37%)
Pre-Market: 20:00
Prenetics Global EPS Diluted (Quarterly) : -0.5203 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5203 |
| March 31, 2026 | -1.360 |
| December 31, 2025 | -1.754 |
| September 30, 2025 | -0.5331 |
| June 30, 2025 | -0.9368 |
| March 31, 2025 | -0.799 |
| December 31, 2024 | -1.276 |
| September 30, 2024 | -0.8388 |
| June 30, 2024 | -0.8772 |
| March 31, 2024 | -0.7014 |
| December 31, 2023 | -1.572 |
| Date | Value |
|---|---|
| September 30, 2023 | -1.156 |
| June 30, 2023 | -2.058 |
| March 31, 2023 | -0.9882 |
| December 31, 2022 | 0.2091 |
| September 30, 2022 | -3.176 |
| June 30, 2022 | -43.59 |
| March 31, 2022 | 1.904 |
| December 31, 2021 | -7.278 |
| September 30, 2021 | -21.29 |
| June 30, 2021 | -3.738 |
| March 31, 2021 | -0.0015 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Global Cord Blood Corp. | -- |
| Exlites Holdings International, Inc. | -0.0001 |
| Xcelerate, Inc. | -0.0001 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Fresenius SE & Co. KGaA | 0.1971 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.088M |
| Revenue (Quarterly) | 46.49M |
| Total Expenses (Quarterly) | 55.58M |
| Enterprise Value | 256.60M |
| Gross Profit Margin (Quarterly) | 64.97% |
| Profit Margin (Quarterly) | -19.55% |
| Earnings Yield | -19.08% |
| Normalized Earnings Yield | -14.25 |